scispace - formally typeset
Search or ask a question

Showing papers by "Henry Buchwald published in 1991"


Journal ArticleDOI
TL;DR: In this article, a case-control study was conducted to assess the possible causes for the increased incidence of kidney stones in partial ileal bypass (PIB) surgery patients.

23 citations


Journal Article
TL;DR: Based on results, all PIB patients appear to be at risk for kidney stone formation and the combination of reduced urinary volume and calcium oxalate precipitation inhibitor substance with increased calcium Oxalate relative supersaturation produced an increase in nephrolithiasis risk in the PIB groups.

23 citations


Journal ArticleDOI
TL;DR: Comparisons of the POSCH patient population to populations of participants in other lipid-lowering trials are presented to provide a perspective on how POSCH relates to these trials.

17 citations


Journal Article
TL;DR: Significant evidence is provided supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression and sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease.

13 citations



Journal Article
TL;DR: An orthopedic catheter for long-term access to the synovial joint is anchored by a hollow threaded tap that penetrates the capsule through a hole drilled in the surrounding bone to allow continuous or intermittent perfusion or sampling.
Abstract: An orthopedic catheter for long-term access to the synovial joint is anchored by a hollow threaded tap that penetrates the capsule through a hole drilled in the surrounding bone. The proximal end of the catheter is connected to either an implantable drug infusion pump or an implantable access port for continuous or intermittent perfusion or sampling. Four catheters were evaluated in dogs. Three were attached to ports, the fourth to a pump. Water (one trial, 22 weeks) and hyaluronic acid (HA) (5 mg/ml; two trials of 8 weeks each) were administered through ports twice weekly in 1.5 ml boluses; 5 mg/ml HA was delivered by pump (1 trial of 33 weeks) at 0.31 ml/day.

4 citations